Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Sell
2,687
-324
-11% -$29.6K 0.05% 138
2026
Q1
$309K Buy
3,011
+6
+0.2% +$677 0.08% 115
2025
Q4
$376K Sell
3,005
-118
-4% -$15K 0.09% 104
2025
Q3
$418K Buy
3,123
+29
+0.9% +$3.81K 0.11% 98
2025
Q2
$421K Buy
3,094
+5
+0.2% +$659 0.13% 86
2025
Q1
$410K Buy
3,089
+6
+0.2% +$764 0.14% 82
2024
Q4
$349K Buy
+3,083
New +$356K 0.12% 84

Other funds holding ABT

CLG LLC's ABT Position: Q2 2026 in Review

CLG LLC reduced its Abbott (ABT) stake by 11% in Q2 2026, selling an estimated $29.6K and leaving 2,687 shares worth $244K. The position accounts for 0.05% of the portfolio, ranked #138.

CLG LLC first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $421K in Q2 2025. 940 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • CLG LLC held 2,687 shares of Abbott worth $244K as of Q2 2026.
  • CLG LLC sold 324 Abbott shares in Q2 2026, an estimated $29.6K.
  • Abbott made up 0.05% of CLG LLC's portfolio in Q2 2026, its #138 holding.
  • CLG LLC first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • CLG LLC's Abbott position peaked at $421K in Q2 2025.
  • 940 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on CLG LLC's 13F filing for Q2 2026, filed 16 Jul 2026.